Functional mitral regurgitation and chronic heart failure

Minerva Cardioangiologica

Volumn 54, Issue 6, 2006, Pages 725-733

  Ennezat, P V ^a   Marechaux, S ^a   Asseman, P ^a   Lejemtel, T H ^b   Van Belle, E ^a   Bauters, C ^a   De Groote, P ^a  

^a Cardiology Hospital   (France)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure, congestive; Mitral insufficiency; Mitral valve

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANNULOPLASTY; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE HEART FAILURE; HEART BLOOD VESSEL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART VALVE PROSTHESIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; MITRAL VALVE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PROGNOSIS; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; HEART FAILURE, CONGESTIVE; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847322204     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Desjardins VA, Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 1996;100:149-56.
2. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991;122:763-71.
3. Ghio S, Freemantle N, Serio A, Magrini G, Scelsi L, Pasotti M et al. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study). Eur J Echocardiogr 2006;7:373-8.
4. Matsuzaki M, Yonezawa F, Toma Y, Miura T, Katayama K, Fujii T et al. [Experimental mitral regurgitation in ischemia-induced papillary muscle dysfunction]. J Cardiol Suppl 1988;18:121-126, discussion 127. Japanese.
5. Miller GE Jr, Keith WJ, Gerbode F. Experimental papillary muscle infarction. J Thorac Cardiovasc Surg 1968;56:611-6.
6. Kaul S, Spotnitz WD, Glasheen WP, Touchstone DA. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation 1991;84:2167-80.
7. Liel-Cohen N, Guerrero JL, Otsuji Y, Handschumacher MD, Rudski LG, Hunziker PR et al. Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from 3-dimensional echocardiography. Circulation 2000;101:2756-63.
8. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:355-9.
9. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000;102:1400-6.
10. Hung J, Otsuji Y, Handschumacher MD, Schwammenthal E, Levine RA. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol 1999;33:538-45.
11. rd. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 2004;44:1619-25.
12. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-70.
13. Rokey R, Sterling LL, Zoghbi WA, Sartori MP, Limacher MC, Kuo LC et al. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol 1986;7:1273-8.
14. Hall SA, Brickner ME, Willett DL, Irani WN, Afridi I, Grayburn PA. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation 1997;95:636-42.
15. Bargiggia GS, Tronconi L, Sahn DJ, Recusani F, Raisaro A, De Servi S et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation 1991;84:1481-9.
16. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
17. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64.
18. Keren G, Bier A, LeJemtel TH. Improvement in forward cardiac output without a change in ejection fraction during nitroglycerin therapy in patients with functional mitral regurgitation. Can J Cardiol 1986;2:206-11.
19. Stevenson LW, Bellil D, Grover-McKay M, Brunken RC, Schwaiger M, Tillisch JH et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:654-8.
20. Keren G, Laniado S, Sonnenblick EH, Lejemtel TH. Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study. Am Heart J 1989;118:748-54.
21. Heinle SK, Tice FD, Kisslo J. Effect of dobutamine stress echocardiography on mitral regurgitation. J Am Coll Cardiol 1995;25:122-7.
22. Keren G, Katz S, Strom J, Sonnenblick EH, LeJemtel TH. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989;80:306-13.
23. Lebrun F, Lancellotti P, Pierard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 2001;38:1685-92.
24. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2003;42:1921-8.
25. Ennezat PV, Marechaux S, Le Tourneau T, Lamblin N, Bauters C, Van Belle E et al. Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J 2006;27:679-83.
26. Lancellotti P, Stainier PY, Lebois F, Pierard LA. Effect of dynamic left ventricular dyssynchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am J Cardiol 2005;96:1304-7.
27. Oral H, Sivasubramanian N, Dyke DB, Mehta RH, Grossman PM, Briesmiester K et al. Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation 2003;107:831-7.
28. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 2004;10:285-91.
29. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997;29:153-9.
30. Robbing JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-2.
31. Lancellotti P, Troisfontaines P, Toussaint AC, Pierard LA. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 2003;108:1713-7.
32. Lancellotti P, Gerard PL, Pierard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005;26:1528-32.
33. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004;43:1584-9.
34. Seneviratne B, Moore GA, West PD. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. Br Heart J 1994;72:63-8.
35. Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999;83:1201-5.
36. Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000;139:596-608.
37. Ennezat PV, Gal B, Kouakam C, Marquie C, LeTourneau T, Klug D et al. Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study. Heart 2006;92:1091-5.
38. Lancellotti P, Melon P, Sakalihasan N, Waleffe A, Dubois C, Bertholet M et al. Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol 2004;94:1462-5.
39. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
40. Smolens IA, Pagani FD, Bolling SF. Mitral valve repair in heart failure. Eur J Heart Fail 2000;2:365-71.
41. McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004;128:916-24.
42. Enomoto Y, Gorman JH 3rd, Moainie SL, Guy TS, Jackson BM, Parish LM et al. Surgical treatment of ischemic mitral regurgitation might not influence ventricular remodeling. J Thorac Cardiovasc Surg 2005;129:504-11.
43. rd, Jackson BM, Plappert T, Enomoto Y et al. Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. J Am Coll Cardiol 2004;43:377-83.
44. Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001;122:1125-41.
45. Thourani VH, Weintraub WS, Guyton RA, Jones EL, Williams WH, Elkabbani S et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation 2003;108:298-304.
46. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation 1983;68:II76-82.
47. Zussa C, Polesel E, Rocco F, Galloni M, Frater RW, Valfre C. Surgical technique for artificial mitral chordae implantation. J Card Surg 1991;6:432-8.
48. Hung J, Guerrero JL, Handschumacher MD, Supple G, Sullivan S, Levine RA. Reverse ventricular remodeling reduces ischemic mitral regurgitation: echo-guided device application in the beating heart. Circulation 2002;106:2594-600.
49. rd, Jackson BM, Gorman RC, Suzuki Y et al. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation 1999;99:135-42.
50. Messas E, Guerrero JL, Handschumacher MD, Conrad C, Chow CM, Sullivan S et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001;104:1958-63.
51. Fayad G, Modine T, Le Tourneau T, Al-Ruzzeh S, Ennezat PV, Decoene C et al. Chordal cutting technique through aortotomy: a new approach to treat chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005;129:1173-4.